Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients

Completed · Phase 2

Conditions studied: Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative

In brief

The purpose of this study is to determine the effectiveness of this medication in preventing nausea and vomiting in female patients at risk for post-operative nausea and vomiting (PONV).

Key facts

Study ID

NCT00600990

Run by

GlaxoSmithKline

People needed

624

Starts

2004-12-01

Expected to finish

2006-07-01

Last updated by the study team

2017-01-20

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• known risk factors for PONV.
• Undergoing gynecological or gallbladder surgery.

Where it is running

• GSK Investigational Site — Glendale, California, United States
• GSK Investigational Site — Laguna Hills, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Pasadena, California, United States
• GSK Investigational Site — Boca Raton, Florida, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Omaha, Nebraska, United States
• GSK Investigational Site — Albany, New York, United States
• GSK Investigational Site — New York, New York, United States
• GSK Investigational Site — Durham, North Carolina, United States
• GSK Investigational Site — Raleigh, North Carolina, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — Houston, Texas, United States
• GSK Investigational Site — Spokane, Washington, United States
• GSK Investigational Site — St Leonards, New South Wales, Australia
• GSK Investigational Site — Westmead, New South Wales, Australia
• GSK Investigational Site — Carlton, Victoria, Australia
• GSK Investigational Site — Melbourne, Victoria, Australia
• GSK Investigational Site — Ringwood East, Victoria, Australia
• GSK Investigational Site — Subiaco, Western Australia, Australia
• GSK Investigational Site — Brussels, Belgium
• GSK Investigational Site — Brussels, Belgium
• GSK Investigational Site — Little Rock, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.